Additionally, mutations in several genes, such as phosphatidylinositol 3-kinase catalytic alpha (PIK3CA), phosphatase and tensin homolog (PTEN), and Kirsten rat sarcoma viral oncogene homolog (KRAS), play a significant role in NSCLC development (22). This evidence concerns the gene PIK3CA and non-small cell lung carcinoma.